Improving Brain Health in Older Adults with Colorectal Cancer
Using Exercise Prehabilitation During Chemotherapy
Led by Dr. Chris Gaffney · Updated on 2026-09-09
86
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Colorectal cancer rates in the North West are 37% higher than the national average, with poorer overall survival rates. Chemotherapy drugs like fluorouracil, capecitabine, and oxaliplatin are commonly used but can cause chemo-brain, which leads to memory and thinking difficulties. This study aims to assess if an exercise-based prehabilitation program can reduce chemo-brain symptoms, improve brain health, and enhance quality of life in older adults undergoing chemotherapy for colorectal cancer.
Participants will take part in a remote exercise program before and during chemotherapy. This includes four 40-minute sessions weekly, with two supervised online sessions and two independent sessions supported by exercise materials. The program combines aerobic and resistance exercises tailored to individual ability, along with daily multivitamin supplements and weekly behavioral support calls. The exercise tolerance and session count will gradually increase and continue throughout the chemotherapy period.
Assessments occur at three main visits before chemotherapy, shortly after starting chemotherapy, and soon after completing chemotherapy, with a follow-up three months later. These include fitness tests, blood samples, brain activity monitoring via EEG, cognitive tests, and quality of life questionnaires. Safety is closely monitored, and all procedures are conducted under medical supervision. Participation may improve fitness, mood, and quality of life, while contributing valuable research to future cancer care.
CONDITIONS
Brief Title
Chemo Brain Prehab Project
Research Team
C
Christopher Gaffney, BSc (Hons.) MSc PhD FHEA
K
Katie L Hoad, BSc (Hons.) MSc PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Individuals with stage II or III colorectal cancer undergoing chemotherapy with fluorouracil, capecitabine, or oxaliplatin.
Aged 60-85 years old.
Fluent in English
Male and female participants
Not engaged in structured exercise training within the six months before providing consent.
You will not qualify if you...
Presence of comorbidities that may significantly alter the metabolic response to exercise, such as diabetes mellitus.
Contraindications to the multivitamin supplement including hypercalcaemia, haemochromatosis, peanut or soya allergy, use of phenytoin or tetracycline antibiotics, and significant kidney or liver problems.
Pre-existing cognitive impairment such as dementia or neurodegenerative disorders.
Diagnosis of atrial fibrillation or haematological malignancy.
Lack of home internet access.
Profound hearing loss.
Receiving palliative care.
Presence of synchronous cancer.
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Prehabilitation and Chemotherapy
Duration - 3 to 4 weeks before chemotherapy and throughout chemotherapy treatment
Participants in the exercise group complete a remote exercise program four times per week, including supervised online sessions and independent sessions, along with daily multivitamins and weekly support calls. The program starts before chemotherapy and continues throughout treatment. The control group receives chemotherapy without the exercise program.
Weekly telephone check-ups and supervised exercise sessions twice a week
Assessments and Follow-up
Duration - Up to 3 months after chemotherapy
Participants complete assessments including fitness tests, blood samples, brain activity monitoring, cognitive tests, and quality of life questionnaires at baseline, during chemotherapy, after chemotherapy, and a follow-up three months later.
3 assessment visits and follow-up evaluations
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Study of 177LuBetaBart Monoclonal Antibody for Safety and Early Effects in Adults With Advanced Solid Tumors
Evaluating 18F-T2 PETCT Imaging for Detecting Tumors with High CAIX Levels in Adults
Phase 12a Study of 64Cu-LNTH-1363S PETCT Imaging in Patients with Sarcoma or Gastrointestinal Tract Cancer
Evaluating Safety, Dosage, and Imaging Correlation with FAP Expression
Study of 18FFPyQCP PET Imaging for Fibroblast Activation Protein in Selected Cancers
Phase 2 Study of 68GaBED003 PET Imaging for Detecting Fibroblast Activation Protein in Colorectal, Gastric, Pancreatic, Breast, and Ovarian Cancers
Study Evaluating Sacituzumab Tirumotecan Alone or With Other Cancer Treatments for Advanced Gastrointestinal Cancers
Evaluating TQB2930 Injection and Chemotherapy With or Without Bevacizumab in Adults With HER2-Abnormal Locally Advanced or Metastatic Colorectal Cancer
Phase I Study of Intravenous CEA-Targeted CAR-T Therapy for Advanced CEA Positive Solid Tumors
Community Screening Study Using Polygene Methylation Testing for Colorectal Cancer in Yangzhou Residents Aged 40 to 74
Study Comparing Early and Late Onset Colorectal Cancer
Investigating Clinical, Socioeconomic, Genetic, and Molecular Factors
Assessing Cancer Recurrence and Survival Outcomes
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The role of prehabilitation in improving brain health and cognition after chemotherapy in patients with colorectal cancer: Study protocol of the Chemo Brain Prehab Project.
Katie Lauren Hoad, Chan Ton, Deborah Williamson...